Mrs. Winslow's Soothing Syrup
Mrs. Winslow's Soothing Syrup was a patent medicine marketed as a cure for teething pains in infants. First introduced to the American public in 1849 by Jeremiah Curtis and Benjamin A. Perkins in Bangor, Maine, it became one of the most popular and widely sold remedies of the 19th century. Despite its initial acclaim, the syrup later garnered significant controversy due to its opiate content, which led to the deaths of infants and contributed to the early regulation of medicines.
Composition[edit]
The primary active ingredient in Mrs. Winslow's Soothing Syrup was morphine, a potent opiate. The syrup also contained alcohol and sugar, making it palatable to infants. The combination of these ingredients was intended to soothe the pain and discomfort of teething, but it also posed serious risks of overdose and addiction.
History[edit]
The syrup was named after Mrs. Charlotte N. Winslow, who was introduced as a nurse with extensive experience in caring for infants. However, historical records suggest that Mrs. Winslow may have been a fictional character created for marketing purposes. The product's widespread popularity grew through aggressive advertising in newspapers and magazines, promising mothers relief from the trials of teething babies.
As the 19th century progressed, the dangers associated with opiate-based medicines like Mrs. Winslow's Soothing Syrup became increasingly evident. Reports of infant mortality and morbidity linked to the syrup and similar products began to surface, leading to public outcry and demands for regulatory action.
Regulation and Legacy[edit]
The controversy surrounding Mrs. Winslow's Soothing Syrup and other patent medicines containing opiates played a significant role in the passage of the Pure Food and Drug Act of 1906 in the United States. This legislation required the labeling of products with their active ingredients, serving as a precursor to modern drug regulation.
Despite its eventual decline in popularity and the cessation of its production, Mrs. Winslow's Soothing Syrup remains a notable example of the dangers posed by unregulated patent medicines. It also highlights the importance of regulatory oversight in ensuring the safety and efficacy of pharmaceutical products.
See Also[edit]
Mrs. Winslow's Soothing Syrup[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
